Training scientists to improve tuberculosis diagnosis and treatment
Official title: Mentoring patient-oriented translational research in tuberculosis
Funded at Stanford University · NIH-11074112 · Data updated 2026-11-12
This study is all about finding better ways to spot and treat tuberculosis (TB) while keeping side effects low, and it's designed for new scientists who want to help improve TB care in real-life situations, especially in Brazil.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | April 11, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $170,802 |
| NIH project number | 5K24AI182647-02 |
| Project ID | NIH-11074112 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of tuberculosis or those currently diagnosed with the disease.
✕Less likely to help
Patients who do not have tuberculosis or are not at risk for the disease may not benefit from this research.
What this research studies
This research focuses on enhancing the early detection and effective treatment of tuberculosis (TB) while minimizing side effects. It aims to train new scientists in patient-oriented research, specifically targeting critical issues in TB diagnosis, treatment, and prevention. The project involves developing innovative tools and methodologies that can be applied in real-world settings, particularly in collaboration with ongoing clinical studies in Brazil. By mentoring early career investigators, the research seeks to foster a new generation of experts dedicated to tackling TB.
Why it matters
Potential benefit: If successful, this research could lead to improved TB diagnosis and treatment strategies, ultimately reducing the global burden of the disease.
How similar studies have gone: Previous research has shown success in developing new TB diagnostic tools and treatment strategies, indicating that this approach has potential for impactful outcomes.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Andrews, Jason Randolph — Stanford University
- Study coordinator: Andrews, Jason Randolph
Related research
Other NIH-funded projects on the same topics.
-
Coronary disease and immune activation in people with HIV and tuberculosis coinfection
This research looks at how having HIV and latent tuberculosis together might raise the risk of heart disease, and what immune changes are involved.
-
Pulmonary rehabilitation to reduce breathing problems after tuberculosis
A program of guided exercise and breathing training to help adults who have recovered from TB breathe better and feel healthier.
-
Pulmonary rehab to reduce breathing troubles after TB
A program of pulmonary rehabilitation is being studied to help adults who have completed TB treatment avoid ongoing lung problems and improve daily breathing.
-
Air pollution and tuberculosis spread in Kampala, Uganda
This project looks at whether dirty air from PM2.5 particles makes tuberculosis more likely to spread within urban slum households in Kampala, Uganda.
-
Air pollution and TB spread in Ugandan urban slums
This project explores whether exposure to air pollution makes tuberculosis more likely to spread within households in a crowded Ugandan slum.
-
Air pollution and TB transmission in Kampala’s urban slums
This project looks at whether air pollution from PM2.5 makes tuberculosis spread more easily from infected people to their neighbors in urban slums of Kampala, Uganda.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.